explore -WSS

explore

author：Wikipedia 2025-10-01 10:58:22 - browse：85

NIH headquarters — NIH research fellows want to unionize, in large part because they want a raise. Will that mean less money for grants? Lydia Polimeni/NIH

Several thousand research fellows at the National Institutes of Health want to unionize, in large part because they want to raise their pay stipends to something resembling a living wage near the agency headquarters in Bethesda, Md. But with a Congress that is looking on in suspicion at the NIH’s research and a debt ceiling deal that limits budget increases, where is the money going to come from?

Unlike private companies, federal agencies can’t always just give raises. This varies widely across the government, and from position to position. NIH trainees actually have it better than most, because they aren’t subject to the rigid federal pay scale that governs how much most people working in the administration can make. That doesn’t mean, however, that there’s always money for raises. It’s Congress, not the NIH itself, that sets the agency’s budget.

Finding money for raises, therefore, necessarily means taking money from somewhere else, said Richard Freeman, a professor of economics at Harvard.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Chan Zuckerberg Biohub Chicago to focus on inflammation

WSS

Phenylephrine and the overlooked value of the placebo effect

New report analyzes digital physical therapy solutions' effectiveness

My daughter's legacy lives on through her writing, phage therapy

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Why Charlie Gard's case is so disturbing to Americans

Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

knowledge

explore

explore

New air purifier tech could be key to improving indoor air quality

Readers discuss the intersection of pregnancy and addiction

The high cost of giving birth even with insurance

Why Charlie Gard's case is so disturbing to Americans

Tori Bowie and the unacceptable rates of Black maternal death

Coercive sterilizations revealed by STAT prompt outrage

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Statins may not be needed by millions of people, study suggests

Peter Hotez and the public health issue of online harassment

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

focus

A virus, fished out of a lake, may have saved a man’s life

Liquid biopsy for lung cancer is launched by Delfi

Sana to lay off nearly a third of staff, de

Histogen: Failed biotech offers rare public look inside

FDA authorizes Novavax’s updated Covid

FDA rejects Alnylam's heart disease treatment over insufficient data

entertainment

focus

hotspot

focus